Biosimilars Bulletin

December Biosimilars Bulletin: Year-End Highlights

As we approach the end of the year, we wanted to share a few highlights. This was an active year… Read more »

October Biosimilars Bulletin: GRx+Biosims 2023 Recap

October kicked off with our annual GRx+Biosims conference in North Bethesda, Maryland, bringing together prominent experts and key figures from... Read more »

August Biosimilars Bulletin: Recap and Fall Highlights

Biosimilars allies – as everyone returns from the summer, September marks the beginning of a busy fall for the Biosimilars… Read more »

July Biosimilars Bulletin: The Biosimilars Market is Heating Up This Summer

Friends, Right now, the biosimilars market is at a major inflection point, with momentum building in Congress for new drug... Read more »

April Biosimilars Bulletin: Biosimilars Buzz on Capitol Hill

To our biosimilars advocates, April was a busy month in the biosimilars realm. Below you’ll find a recap of last... Read more »

Biosimilars Bulletin | March 2023

To our biosimilars advocates, As you will see below, we have made some changes to our monthly bulletin. Our goal... Read more »

Biosimilars Bulletin | February 2023

A Note from Biosimilars Council Executive Director Craig Burton Thank you to everyone who attended Access! 2023 and helped make... Read more »

Biosimilars Bulletin | January 2023

A Note from Biosimilars Council Executive Director Craig Burton This year has begun where last year ended – with high... Read more »

Biosimilars Bulletin | December 2022

A Note from Biosimilars Council Executive Director Craig Burton As we close out 2022 and move into 2023, we are... Read more »

Biosimilars Bulletin | November 2022

A Note from Biosimilars Council Executive Director Craig Burton First, thank you to all whose attendance and engagement made GRx+Biosims... Read more »

Biosimilars Bulletin | November 2022

A Note from Biosimilars Council Executive Director Craig Burton Although we’re entering November, the Biosimilars Council’s efforts to promote biosimilarsare... Read more »

Biosimilars Bulletin | September 2022

A Note from Biosimilars Council Executive Director Craig Burton September marks the culmination of a significant amount of the Biosimilars... Read more »

Biosimilars Bulletin | August 2022

A Note from Biosimilars Council Executive Director Craig Burton Last month, we witnessed the final passage and enactment of the... Read more »

Biosimilars Bulletin | July 2022

A Note from Biosimilars Council Executive Director Craig Burton As we write this, the Senate is actively considering the Inflation... Read more »
Biosimilar Bulletin June 2022, doctor advising patient.

Biosimilars Bulletin | June 2022

A Note from Biosimilars Council Executive Director Craig Burton This month, both chambers of Congress made progress in advancing legislation... Read more »
Biosimilars patient resource center, bulletin

Biosimilars Bulletin | May 2022

A Note from Former Executive Director Christine Simmon  As many of you have already heard, May was my last month... Read more »
Doctor helping biosimilar patient

Biosimilars Bulletin | April 2022

A Note from Biosimilars Council Executive Director Christine Simmon Biosimilar adoption continues to steadily grow and reach new patients with... Read more »

Biosimilars Bulletin | March 2022

A Note from Biosimilars Council Executive Director Christine Simmon As we close out Women’s History Month, I would like to... Read more »

Biosimilars Bulletin | February 2022

A Note from Biosimilars Council Executive Director Christine Simmon Happily, members of the Biosimilars Council and AAM were able to... Read more »

Your Biosimilars Bulletin | 2021 Year in Review

A Note from Biosimilars Council Executive Director Christine Simmon 2021 proved to be an eventful year for the biosimilars community,... Read more »

Biosimilars Bulletin | November 2021

A Note from Biosimilars Council Executive Director Christine Simmon The second annual Global Biosimilars Week proved a great way to... Read more »

Biosimilars Bulletin | October 2021

A Note from Biosimilars Council Executive Director Christine Simmon This month, the Biosimilars Council announced the release of AAM’s 2021... Read more »
Biosimilar information

Biosimilars Bulletin | September 2021

A Note from Biosimilars Council Executive Director Christine Simmon September was an exciting month, as we announced the topline findings... Read more »
Biosimilar information

Biosimilars Bulletin | August 2021

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry, including policy movement, educational... Read more »

Biosimilars Bulletin | July 2021

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry, including policy movement, educational... Read more »

Biosimilars Bulletin | June 2021

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry, including policy movement, educational... Read more »
biosimilars news january 2021

Biosimilars Bulletin | January 2021

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
biosimilars news december 2020

Biosimilars Bulletin | December 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
biosimilars news november 2020

Biosimilars Bulletin | November 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
biosimilars news october 2020

Biosimilars Bulletin | October 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
biosimilars bulletin september 2020

Biosimilars Bulletin | September 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
Biosimilars News August 2020

Biosimilars Bulletin | August 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
Biosimilars News July 2020

Biosimilars Bulletin | July 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
Biosimilars news June 2020

Biosimilars Bulletin | June 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
Biosimilars News May 2020

Biosimilars Bulletin | May 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
biosimilars news april 2020

Biosimilars Bulletin | April 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
Bulletin March

Biosimilars Bulletin | March 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
twitter chat

Biosimilars Bulletin | February 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »
biosimilars news january 2020

Biosimilars Bulletin | January 2020

Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry including policy movement, educational... Read more »